A clinical staging classification for type C niemann-pick disease

Joseph J. Higgins, M. C. Patterson, J. M. Dambrosia, A. T. Pikus, P. G. Pentchev, S. Sato, R. O. Brady, N. W. Barton

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Abstract

Analysis of the temporal sequence of neurologic events, neurophysiologic abnormalities, and longevity in 36 Niemann-Pick type C patients revealed two clinical subgroups with five stages of severity within each group. Patients with a preschool onset (group I; n = 18) had a higher mortality than did patients with a school-age onset (group II; n = 18). An asymptomatic phase (stage 0) was defined by biochemical and histopathologic evidence of disease. The initial manifestations of stage 1 were a movement disorder (group I) and cognitive difficulties (group II) accompanied by impaired vertical saccadic eye movements and abnormal acoustic reflexes. Stage 2 was characterized by the sequential occurrence of vertical supranuclear gaze palsy (VSGP), cognitive difficulties, and dysarthria in group I and a movement disorder, VSGP, and dysarthria in group II. Pyramidal tract signs and abnormal brainstem auditory evoked responses defined stage 3 in both groups. Stage 4 culminated in a nonambulant, vegetative state.

Original languageEnglish (US)
Pages (from-to)2286-2290
Number of pages5
JournalNeurology
Volume42
Issue number12
DOIs
StatePublished - Dec 1992

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'A clinical staging classification for type C niemann-pick disease'. Together they form a unique fingerprint.

Cite this